Depo-Provera^® Lawsuit Update

What’s Happening With the Depo-Provera Lawsuit?

Depo-Provera is an injectable birth control medication that has been associated with the development of meningioma brain tumors when used for 1 year or more.

Women who used Depo-Provera are 5.5 times more likely to develop a meningioma requiring surgery than non-users​, according to a recent study.

Update on the Depo Shot Lawsuits

• The first Depo-Provera brain tumor lawsuit was filed in October 2024 by a woman who used the contraception between 2005 and 2021.
• Steps are underway to consolidate claims into a Depo-Provera class action lawsuit or multidistrict litigation (MDL).
• Some patients have sued Pfizer Inc., the drug’s manufacturer, alleging it knew or should’ve known about the meningioma risks related to the medication.
• A birth control shot settlement can help brain tumor victims cover their medical expenses, lost wages, and more.

LawFirm.com works with Depo-Provera lawyers who have secured over $1.6 billion for those harmed by dangerous drugs and medical devices.

Our legal partners can even the playing field for victims and work to hold Pfizer accountable. See if they may be able to help you seek compensation and justice with a free case review.

Get the Compensation You Deserve

Take the first step toward compensation and justice.

Get a Free Case Review

Depo Shot Lawsuit Update 2024-2025

For decades, millions of women have relied on the injectable medication for birth control and various health conditions like endometriosis.

However, many are now taking legal action and making their voices heard as they learn about the link between the birth control shot and a type of brain tumor called a meningioma.

Find out about the latest Depo shot lawsuit updates and how they may affect case values as these claims move forward

1. Consolidation of Depo-Provera Claims Underway

Depo-Provera Class Action Lawsuit Update: January 7, 2025

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has scheduled a hearing to decide if it will consolidate the growing number of Depo-Provera brain tumor claims into multidistrict litigation, which is similar to a class action lawsuit.

MDLs streamline the litigation of large, complex cases, like those involving dangerous pharmaceuticals. They allow victims to share evidence but retain their individual claims.

That would be important in birth control shot lawsuits, as victims’ injuries and damages are likely to vary depending on factors like the type and size of their brain tumor, medical expenses, and long-term impairment.

2. Louisiana Woman With Intracranial Meningioma Files Depo Shot Lawsuit

Depo-Provera Lawsuit Update: December 21, 2024

A woman filed a Depo-Provera lawsuit in the Eastern District of Louisiana, claiming the contraceptive injection caused her to develop an intracranial meningioma and impacted her quality of life.

The plaintiff alleges that she started the injections at 18 and wasn’t told about brain tumor risks linked to Depo shot usage. She says the drug’s manufacturers failed to give adequate warnings to U.S. patients or suggest safer alternatives, like a lower-dose version.

3. Pfizer and Others Named in Birth Control Shot Lawsuit

Depo-Provera Lawsuit News: December 11, 2024

A woman in Bakersfield, California, filed a Depo-Provera brain tumor lawsuit in the Eastern District of California against Pfizer and its related entities, Pharmacia & Upjohn Co. LLC and Pharmacia LLC.

She claims she developed an intracranial meningioma after using Depo-Provera from 2009 to 2015 and maintains that the pharmaceutical companies failed to warn her or her health care providers about risks related to long-term use of the contraceptive.

The plaintiff reportedly suffered symptoms including severe headaches, dizziness, and fatigue before being diagnosed with a meningioma.

4. Another Brain Surgery Patient Files a Depo Claim

Depo Shot Lawsuit Update: December 7, 2024

A Depo-Provera injection lawsuit filed in the Philadelphia County Court of Common Pleas claims that prolonged use of Depo-Provera caused a woman to develop a meningioma, which resulted in multiple brain surgeries.

The Depo shot lawsuit also includes claims against health care providers affiliated with the University of Pennsylvania Health System for not suggesting safer birth control alternatives.

By filing a Depo-Provera lawsuit, meningioma patients can pursue compensation for surgeries and other medical care they may need.

5. Multiple Drug Manufacturers Sued in Latest Depo-Provera Lawsuit

Depo Shot Lawsuit Update: December 2, 2024

A woman from Santa Clarita, California, filed claims against numerous pharmaceutical companies — including Pfizer and subsidiaries Prasco and Viatris — for serious injuries allegedly caused by the Depo-Provera shot.

The lawsuit claims that long-term use of the injection, which contains a high dose of synthetic progestin, caused two intracranial meningiomas that required brain surgery. She continues to experience vision loss and other complications, according to the complaint.

The plaintiff alleges that the manufacturers could have minimized risks by promoting safer alternatives. She is seeking compensatory and punitive damages for failure to warn, negligence, and other product liability claims.

6. Motion Filed to Consolidate 22 Depo Lawsuits in California

Depo-Provera Class Action Lawsuit Update: November 30, 2024

A motion seeking to consolidate over 20 Depo-Provera lawsuits under one federal judge in California has been submitted by plaintiffs’ lawyers to the MDL Panel.

The motion involves a total of 22 lawsuits — 18 of them filed in California and others pending in Indiana, Nevada, Massachusetts, and Missouri.

The motion argues that California is the best place for these lawsuits to be heard due to the large number of cases already filed there, and state laws that would permit plaintiffs to sue Pfizer even if they used a generic version of the birth control shot.

7. Long-Term Depo-Provera User Files Lawsuit

Depo-Provera Lawsuit Update: November 19, 2024

A Nevada woman who used Depo-Provera for about 18 years and developed an intracranial meningioma filed a lawsuit against Pfizer and Pharmacia, alleging that they failed to adequately warn about the risks linked to the birth control shot.

She allegedly underwent two invasive brain surgeries in 2015 to remove the tumor and received additional treatments for complications, including a brain bleed. She now suffers from serious side effects like permanent hearing and vision loss, according to the lawsuit.

8. Brain Tumor Patient Sues Drug Makers

Depo-Provera Lawsuit News: November 15, 2024

A Nevada woman and her husband filed a federal lawsuit against Pfizer and other pharmaceutical companies responsible for manufacturing and marketing Depo-Provera and its authorized generic alternatives.

The woman received about 80 injections of the drug over a 20-year period, relying on marketing that claimed the medication is a safe, effective form of birth control.

The lawsuit alleges the woman experienced symptoms like:

• Blurred vision
• Severe headaches
• Swelling near her eyes

Her physician discovered that she had multiple meningioma brain tumors, including one behind her eye. She received a craniotomy to remove the largest tumor and 30 sessions of radiation. However, doctors predict she’ll need additional surgeries and medical monitoring.

Even women who took Depo-Provera years ago and have been diagnosed with a meningioma brain or spinal tumor may be able to file a birth shot lawsuit to seek compensation for their medical bills and emotional distress.

9. Pfizer Warns Patients in Other Countries of Meningioma Risk

Depo Shot Lawsuit Update: October 31, 2024

Pfizer added a meningioma warning to its Depo-Provera label for patients in Europe. The warning states that meningiomas have been reported in patients who have taken progestogens, including medroxyprogesterone acetate, for a prolonged period.

While the U.S. Food and Drug Administration (FDA) required a black box warning on Depo-Provera sold in the U.S. concerning significant bone density loss in long-term users, there’s no warning related to a higher risk of brain tumors.

Companies have a duty to warn of the risks associated with their products. When they fail to do so, they can be held responsible.

10. Pfizer Changes Prescribing Guidelines but Not Warning Label

Depo-Provera News: July 12, 2024

Pfizer changed the guidelines and prescribing information for Depo-Provera. However, the company didn’t make any changes to the drug’s warning label in the U.S., despite research linking the birth control shot to meningiomas.

Depo-Provera lawsuits generally allege that Pfizer knew or should have known of the risks but failed to adequately warn consumers, causing personal injuries and other serious harm.

11. Pfizer Addresses Study Linking Brain Tumors to Depo-Provera Shot

Lawsuit for Depo-Provera Update: April 25, 2024

Pfizer released a public statement about The BMJ study linking the Depo shot to an increased risk of meningioma tumors.

The company said it’s aware of the potential risk associated with long-term use of progestogens and is collaborating with regulatory agencies to update product labels and patient information leaflets.

12. Study Links Long-Term Depo Provera Use to Brain Tumors

Depo Shot News: March 29, 2024

A study published in The British Medical Journal (BMJ) found that women who used Depo-Provera for at least 1 year were 5.5 times more likely to be diagnosed with meningiomas compared with non-users.

These findings have opened the door for victims to file Depo-Provera brain tumor lawsuits and pursue financial compensation for their injuries.

Get a free case review now to see if we may be able to help you get the money and justice you deserve.

Get the Compensation You Deserve

Take the first step toward compensation and justice.

Get a Free Case Review

Depo-Provera Litigation Timeline

For decades, millions of women have relied on Depo-Provera as an effective and safe method of contraception. Now, many victims diagnosed with brain tumors after long-term use are taking legal action.

Find out more about how the litigation has unfolded:

• March 2024: The British Medical Journal (BMJ) links long-term use of the Depo shot to an increased risk of meningioma tumors.
• April 2024: Pfizer, the drug’s manufacturer, responds to The BMJ study by saying it’s aware of the potential risk and is working with regulatory agencies to update labels with appropriate warnings.
• July 2024: Pfizer changes its Depo-Provera prescribing guidelines but still hasn’t changed warning labels that would allow consumers to make informed decisions about their health.
• October 2024: The drug company implements Depo-Provera label changes for patients in the United Kingdom and European Union but not the U.S. This same month, the first Depo-Provera lawsuit is filed by a California woman who used the shot from 2005-2021.
• November 2024: Depo-Provera lawsuits continue to be filed as women learn the possible connection between their meningioma brain tumors and the use of the birth control shot.
• December 2024: A motion to consolidate pending claims in a Depo-Provera class action lawsuit or multidistrict litigation is filed in the state of California.
• January 2025: Over 20 women have filed Depo shot lawsuits, seeking compensation for their medical expenses and pain and suffering.

Our Depo-Provera lawsuit updates allow victims to know what to expect as the litigation moves forward toward potential payouts for those harmed.

Get the Latest News on the Depo-Provera Lawsuit

The Depo-Provera lawyers in the LawFirm.com network are at the forefront of this area of rapidly developing litigation and are ready to help brain tumor victims seek justice.

If you or a loved one suffered a meningioma brain or spinal tumor, you may qualify for compensation from a Depo shot lawsuit.

Call (888) 726-9160 right now or get a free, no-obligation case review to see if we may be able to help you pursue the compensation you deserve.